CCM
EUCRU

Condor Capital Management’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

Condor Capital Management’s Portfolio EUCRU Stock Details EUCRU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,600
Closed -$26K – 390
2022
Q3 		$26K Buy
2,600
+800
+44% +$7.97K ﹤0.01% 350
2022
Q2 		$18K Sell
1,800
-800
-31% -$7.94K ﹤0.01% 371
2022
Q1 		$26K Hold
2,600
– – ﹤0.01% 315
2021
Q4 		$26K Hold
2,600
– – ﹤0.01% 284
2021
Q3 		$26K Hold
2,600
– – ﹤0.01% 250
2021
Q2 		$27K Hold
2,600
– – ﹤0.01% 247
2021
Q1 		$26K Buy
+2,600
New +$27.7K ﹤0.01% 240

Other funds holding EUCRU

Verition Fund Management
Verition Fund Management Greenwich, Connecticut $10.3B AUM 30.69% 1-Year Est. Return
SCM
Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $6.41B AUM 4.78% 1-Year Est. Return
CS
Clear Street New York $17.8B AUM 56.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return